The role of osteocyte apoptosis in cancer chemotherapy‐induced bone loss
- 21 September 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 227 (7) , 2889-2897
Abstract
Intensive cancer chemotherapy leads to significant bone loss, the underlying mechanism of which remains unclear. The objective of this study was to elucidate mechanisms for effect of the commonly used anti‐metabolite methotrexate (MTX) on osteocytes and on general bone homeostasis. The current study in juvenile rats showed that MTX chemotherapy caused a 4.3‐fold increase in the number of apoptotic osteocytes in tibial metaphysis, which was accompanied by a 1.8‐fold increase in the number of tartrate‐resistant acid phosphatase‐positive bone resorbing osteoclasts, and a 35% loss of trabecular bone. This was associated with an increase in transcription of the osteoclastogenic cytokines IL‐6 (10‐fold) and IL‐11 (2‐fold). Moreover, the metaphyseal bone of MTX‐treated animals exhibited a 37.6% increase in the total number of osteocytes, along with 4.9‐fold higher expression of the DMP‐1 transcript. In cultured osteocyte‐like MLO‐Y4 cells, MTX treatment significantly increased caspase‐3‐mediated apoptosis, which was accompanied by the formation of plasma membrane‐born apoptotic bodies and an increase in IL‐6 (24‐fold) and IL‐11 (29‐fold) mRNA expression. Conditioned media derived from MTX‐treated MLO‐Y4 cells was twice as strong as untreated media in its capacity to induce osteoclast formation in primary bone marrow osteoclast precursors. Thus, our in vivo and in vitro data suggested that MTX‐induced apoptosis of osteocytes caused higher recruitment of DMP‐1 positive osteocytes and increased osteoclast formation, which could contribute towards the loss of bone homeostasis in vivo. J. Cell. Physiol. 227: 2889–2897, 2012.Keywords
This publication has 45 references indexed in Scilit:
- Osteocyte Apoptosis Controls Activation of Intracortical Resorption in Response to Bone FatigueJournal of Bone and Mineral Research, 2009
- Life and death by death receptorsThe FASEB Journal, 2009
- Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolismNature Genetics, 2006
- E11/gp38 Selective Expression in Osteocytes: Regulation by Mechanical Strain and Role in Dendrite ElongationMolecular and Cellular Biology, 2006
- Interleukin-11 Receptor Signaling Is Required for Normal Bone RemodelingJournal of Bone and Mineral Research, 2005
- Chemotherapy and the war on cancerNature Reviews Cancer, 2005
- Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosisLife Sciences, 2004
- Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neckBone, 2004
- Osteoclast differentiation and activationNature, 2003
- Establishment of an Osteocyte-like Cell Line, MLO-Y4Journal of Bone and Mineral Research, 1997